Sort
15,273 grants matching “antimicrobial resistance”
Development of WecA-targeting immune potentiators to treat carbapenem-resistant Enterobacteriaceae (CRE) infections
$295,541Terry Roemer · Prokaryotics, Inc. · R44 · FY2019 · AI
Inducible Renitence in Macrophages
$295,450Joel A Swanson · University Of Michigan At Ann Arbor · R01 · FY2014 · GM
Vibrio fischeri as a model of bacterial colonization
$295,375University Of Hawaii At Manoa · R01 · FY2002 · AI
Alpha-AApeptides as a novel class of antimicrobial biomaterials
$295,370Jianfeng Cai · University Of South Florida · R01 · FY2017 · GM
Factor H-Fc Fusion as a Pre-Exposure Prophylactic for Rickettsia Infections
$295,353Keith Wycoff · Planet Biotechnology, Inc. · R43 · FY2025 · AI
Augmentation of Innate Anti-Microbial Immunity by TLR4 Agonists
$295,271Edward R Sherwood · Vanderbilt University · R01 · FY2014 · GM
Synthetic and biological investigations of 2-aminoimidazole derived natural products.
$295,263Ryan Edward Looper · University Of Utah · R01 · FY2017 · GM
Recognition and Signaling During Infection in Drosphila
$295,253Jules A Hoffman · Massachusetts General Hospital · P01 · FY2007 · AI
Role of PA4878 in biofilm antimicrobial resistance
$295,224Karin Sauer · State University Of Ny,Binghamton · R01 · FY2011 · AI
Novel Polymer Additives for Infection Control Intravenous Catheters
$295,203Ekrem Ozkan · Halomine, Inc. · R43 · FY2024 · HL
Development of a Designer Proline-rich antimicrobial peptide Chaperone protein inhibitor (DPC) for treating multi-drug resistant urinary tract infections
$295,171Carl Neil Kraus · Arrevus, Inc. · R41 · FY2018 · AI
Fungal Ras-mediated invasive growth mechanisms
$295,152Jarrod R. Fortwendel · University Of Tennessee Health Sci Ctr · R01 · FY2017 · AI
Peptide Deformylase: Mechanism and Inhibitor Design
$295,000Ohio State University · R01 · FY2003 · AI
Peptide Deformylase: Mechanism and Inhibitor Design
$295,000Ohio State University · R01 · FY2004 · AI
Peptide Deformylase: Mechanism and Inhibitor Design
$295,000Ohio State University · R01 · FY2005 · AI
Genetic Functions of an Enterococcal R Factor
$294,949Gary M Dunny · University Of Minnesota · R01 · FY2008 · GM
New Nosocomial Interventions to Decrease Antimicrobial Resistance Transmission
$294,937Anthony D Harris · University Of Maryland Baltimore · R01 · FY2007 · CI
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
$294,930Randi Hornback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2017 · AI
Peptide Deformylase: Mechanism and Inhibitor Design
$294,916Ohio State University · R01 · FY2002 · AI
Genetic Functions of an Enterococcal R Factor
$294,719Gary M Dunny · University Of Minnesota · R01 · FY2009 · GM
Healthcare Modeling Workforce Development Through Washington State University's Resistance Epidemiology Modeling Initiative
$294,683Eric T Lofgren · Washington State University · U01 · FY2022 · CK
SQ641, new drug candidate to treat NTM infections
$294,661Venkata M Reddy · Sequella, Inc. · R43 · FY2009 · AI
Inducible Renitence in Macrophages
$294,658Joel A Swanson · University Of Michigan At Ann Arbor · R01 · FY2015 · GM
Ocular Disposition of Antimicrobial Agents
$294,609Ashim K Mitra · University Of Missouri Kansas City · R01 · FY2008 · EY
Susceptibility Testing, Treatment Choices, and Outcomes of MDR-GNB Infections
$294,519Lisa L. Maragakis · Johns Hopkins University · R01 · FY2009 · CI